Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects

Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects

The effect of coingestion of fat on the glucose, insulin, and gastric inhibitory polypeptide responses to carbohyd rate and protein

The effect of coingestion of fat on the glucose, insulin, and gastric inhibitory polypeptide responses to carbohyd rate and protein

Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects

Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects

The Brain-Gut-Islet Connection

The Brain-Gut-Islet Connection

(cited by Todd Becker in his HH post)

An Oral Lipid Challenge and Acute Intake of Caffeinated Coffee Additively Decrease Glucose Tolerance in Healthy Men

An Oral Lipid Challenge and Acute Intake of Caffeinated Coffee Additively Decrease Glucose Tolerance in Healthy Men

Incretins decrease??

Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus

Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus

Mechanisms of Action of GLP-1 in the Pancreas

Mechanisms of Action of GLP-1 in the Pancreas

Hormone-Sensitive Lipase Has a Role in Lipid Signaling for Insulin Secretion but Is Nonessential for the Incretin Action of Glucagon-Like Peptide 1

Hormone-Sensitive Lipase Has a Role in Lipid Signaling for Insulin Secretion but Is Nonessential for the Incretin Action of Glucagon-Like Peptide 1

Islet β cell failure in type 2 diabetes

Glucagon-like peptide 1 (1–37) converts intestinal epithelial cells into insulin-producing cells

Glucagon-like peptide 1 (1–37) converts intestinal epithelial cells into insulin-producing cells

A GIP Receptor Agonist Exhibits β-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved β-Cell Function and Glycemic Control

A GIP Receptor Agonist Exhibits β-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved β-Cell Function and Glycemic Control

Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes

Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity